/OGI.TO

OGI.TO Stock - OrganiGram Holdings Inc.

Q: What is the analyst price target for OGI.TO?

Analyst price target information is not currently available for OGI.TO.

Q: What is OGI.TO's market cap?

Market capitalization information is not currently available for OGI.TO.

Healthcare|Drug Manufacturers - Specialty & Generic|TSX

$2.64-4.35%

$0.12 (-4.35%) • Dec 22

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $2.90

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for OGI.TO

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

FY2023

FY2024

FY2025

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta2.26

52W High$3.09

52W Low$1.22

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$259.18M	$159.84M	$149.21M	$145.81M	$79.16M
Gross Profit	$9.51M	$47.52M	$35.07M	$31.57M	$-28,399,000
Gross Margin	3.7%	29.7%	23.5%	21.7%	-35.9%
Operating Income	$-88,308,000	$-35,671,000	$-242,739,000	$-43,151,000	$-91,820,000
Net Income	$-24,759,000	$-45,440,000	$-229,478,000	$-14,283,000	$-130,704,000
Net Margin	-9.6%	-28.4%	-153.8%	-9.8%	-165.1%
EPS	$-0.19	$-0.48	$-2.82	$-0.18	$-2.04

Company Overview

Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.

Visit Website

Earnings History & Surprises

OGI.TO

Beat Rate

22%

Last 18 quarters

Avg Surprise

-417.1%

EPS vs Estimate

Beats / Misses

4/13

1 met exactly

Latest EPS

$-0.28

Q4 2025

EPS Surprise History

Q4 23

+7.1%

$-0.13vs$-0.14

Q1 24

-147.5%

$-0.30vs$-0.12

Q2 24

-188.9%

$-0.26vs$-0.09

Q3 24

+142.9%

$0.03vs$-0.07

Q4 24

-125.0%

$-0.09vs$-0.04

Q1 25

-400.0%

$-0.20vs$-0.04

Q3 25

-370.0%

$-0.05vs$-0.01

Q4 25

-4123.9%

$-0.28vs$-0.01

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 11, 2026	—	—	—	—
Q1 2026	Feb 10, 2026	—	—	—	—
Q4 2025	Dec 16, 2025	$-0.01	$-0.28	-4123.9%	✗ MISS
Q3 2025	Aug 13, 2025	$-0.01	$-0.05	-370.0%	✗ MISS
Q1 2025	Feb 11, 2025	$-0.04	$-0.20	-400.0%	✗ MISS
Q4 2024	Dec 17, 2024	$-0.04	$-0.09	-125.0%	✗ MISS
Q3 2024	Aug 13, 2024	$-0.07	$0.03	+142.9%	✓ BEAT
Q2 2024	May 14, 2024	$-0.09	$-0.26	-188.9%	✗ MISS
Q1 2024	Feb 13, 2024	$-0.12	$-0.30	-147.5%	✗ MISS
Q4 2023	Dec 19, 2023	$-0.14	$-0.13	+7.1%	✓ BEAT
Q3 2023	Jul 13, 2023	$-0.05	$-0.68	-1260.0%	✗ MISS
Q2 2023	Apr 11, 2023	$-0.01	$-0.02	-37.2%	✗ MISS
Q1 2023	Jan 22, 2023	$0.00	$0.02	+326.4%	✓ BEAT
Q4 2022	Nov 29, 2022	$-0.02	$-0.02	0.0%	= MET
Q3 2022	Jul 14, 2022	$-0.02	$-0.09	-414.3%	✗ MISS
Q2 2022	Apr 12, 2022	$-0.01	$-0.01	-44.7%	✗ MISS
Q1 2022	Jan 11, 2022	$-0.03	$-0.05	-87.5%	✗ MISS
Q4 2021	Nov 23, 2021	$-0.04	$-0.09	-136.8%	✗ MISS
Q3 2021	Jul 13, 2021	$-0.05	$-0.01	+80.0%	✓ BEAT
Q2 2021	Apr 13, 2021	$-0.04	$-0.29	-728.6%	✗ MISS

Frequently Asked Questions about OGI.TO

What is OGI.TO's current stock price?

OrganiGram Holdings Inc. (OGI.TO) is currently trading at $2.64 per share. The stock has moved -4.35% today.

What is the analyst price target for OGI.TO?

No analyst price targets are currently available for this stock.

What sector is OrganiGram Holdings Inc. in?

OrganiGram Holdings Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the TSX exchange.

What is OGI.TO's market cap?

OrganiGram Holdings Inc. has a market capitalization of $0.35 billion, making it a small-cap company.

Does OGI.TO pay dividends?

No, OrganiGram Holdings Inc. does not currently pay a dividend to shareholders.